Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 11:33 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 10:00 AM ISTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
USFDA flags heart inflammation risk after taking Novavax COVID vaccine Ruchika Sharma4 Jun 2022 3:09 PM ISTThe FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.
Novavax seeks Taiwan FDA emergency use nod for COVID-19 vaccine Ruchika Sharma14 May 2022 10:00 AM ISTUnited States: Novavax has announced the submission of a request for emergency use authorization to Taiwan's Food and Drug Administration for its...
Novavax 2022 COVID vaccine deliveries off to slow start, shares drop Ruchika Sharma11 May 2022 9:00 AM ISTNew Delhi: Novavax Inc on Monday revealed a sharp drop in first-quarter COVID-19 research funding and said it shipped less than a fourth of the total...
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
USFDA VRBPA committee to review Novavax COVID vaccine Ruchika Sharma2 May 2022 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2.
Early trial of Novavax COVID-Influenza vaccine shows promise Ruchika Sharma23 April 2022 10:00 AM ISTThe safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...
Novavax partner gets Japenese nod for Nuvaxovid Ruchika Sharma19 April 2022 5:18 PM ISTNovavax licensed and transferred its manufacturing technologies and is supplying the Matrix-M adjuvant to enable Takeda to manufacture the vaccine at...
Novavax seeks conditional marketing nod for Nuvaxovid in adolescents Ruchika Sharma3 April 2022 9:00 AM ISTGaithersburg: Novavax, Inc. has announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid COVID-19...
